Pfizer Goodwill and Intangible Assets 2010-2024 | PFE

Pfizer goodwill and intangible assets for the quarter ending June 30, 2024 were $129.685B, a 39.48% increase year-over-year.

  • Pfizer goodwill and intangible assets for 2023 were $132.683B, a 40.04% increase from 2022.
  • Pfizer goodwill and intangible assets for 2022 were $94.745B, a 27.42% increase from 2021.
  • Pfizer goodwill and intangible assets for 2021 were $74.354B, a 4.54% decline from 2020.

Pfizer Goodwill and Intangible Assets 2010-2024 | PFE

  • Pfizer goodwill and intangible assets for 2023 were $132.683B, a 40.04% increase from 2022.
  • Pfizer goodwill and intangible assets for 2022 were $94.745B, a 27.42% increase from 2021.
  • Pfizer goodwill and intangible assets for 2021 were $74.354B, a 4.54% decline from 2020.
Related Stocks
Company NameMarket
Cap
Eli Lilly (LLY)$860.1B
Novo Nordisk (NVO)$592.6B
Johnson & Johnson (JNJ)$400B
AbbVie (ABBV)$340.8B
Merck (MRK)$300.5B
AstraZeneca (AZN)$243.6B
Novartis AG (NVS)$237B
Sanofi (SNY)$145.6B
Innoviva (INVA)$1.2B